Measuring Permeability in Human Retinal Epithelial Cells (ARPE-19): Implications for the Study of Diabetic Retinopathy

Methods in Molecular Biology

Volumn 763, Issue , 2011, Pages 179-194

  Garcia Ramírez, Marta ^a   Villarroel, Marta ^a   Corraliza, Lídia ^a   Hernández, Cristina ^a   Simó, Rafael ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

ARPE 19 cells; Blood retinal barrier; Dextran permeability; Diabetic retinopathy; Retinal pigment epithelium; Tight junctions; Transepithelial electrical resistance

Indexed keywords

DEXTRAN; GLUCOSE; MEMBRANE PROTEIN; OCCLUDIN; PHOSPHOPROTEIN; PROTEIN ZO1; ZONULA OCCLUDENS-1 PROTEIN;

ARTICLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CONFOCAL MICROSCOPY; CYTOLOGY; DIABETIC RETINOPATHY; DIFFUSION CHAMBER; DRUG EFFECT; EPITHELIUM CELL; FLUORESCENCE; GENETICS; HUMAN; IMPEDANCE; METABOLISM; METHODOLOGY; PATHOLOGY; PERMEABILITY; PIGMENT EPITHELIUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; POTENTIOMETRY; REAL TIME POLYMERASE CHAIN REACTION; RETINA; TIGHT JUNCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE PERMEABILITY; DEXTRANS; DIABETIC RETINOPATHY; DIFFUSION CHAMBERS, CULTURE; ELECTRIC IMPEDANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; FLUORESCENCE; GLUCOSE; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; PERMEABILITY; PHOSPHOPROTEINS; POTENTIOMETRY; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RETINAL PIGMENT EPITHELIUM; TIGHT JUNCTIONS;

EID: 80054740186     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-191-8_12     Document Type: Chapter

References (19)

1. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845–881
2. Holtkamp GM, Kijlstra A, Peek R, de Vos AF (2001) Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 20:29–48
3. Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier. Implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010: 190724
4. Congdon N, Friedman DS, Lietman T (2006) Important causes of visual impairment in the world today. JAMA 290:2057–2060
5. Lightman S, Towler HM (2003) Diabetic retinopathy. Clin Cornerstone 5:12–21
6. Tong L, Vernon SA, Kiel W, Sung V, Orr GM (2001) Association of macular involvement with proliferative retinopathy in type 2 diabetes. Diabet Med 18:388–394
7. Simó R, Carrasco E, García-Ramírez M, Hernández C (2006) Angiogenic and antian-giogenic factors in proliferative diabetic retinopathy. Curr Diabet Rev 2:71–98
8. Joussen A, Smyth N, Niessen C (2007) Pathophysiology of diabetic macular edema. Dev Ophthalmol 39:1–12
9. Dunn KC, Aotaki-Keen AE, Putkey FR, Hielmeland LM (1996) ARPE-19 a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155–169
10. Abe, T, Sugano, E, Saigo, Y, Tamai, M (2003) Interleukin-1b and barrier function of retinal pigment epithelial cells (ARPE-19): aberrant expression of junctional complex molecules. Invest Ophthalmol Vis Sci 44:4097–4104
11. Phillips BE, Cancel L, Tarbell JM, Antonetti DA (2008) Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 49:2568–2576
12. Villarroel M, García-Ramírez M, Corraliza L, Hernández C, Simó R (2009) Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Exp Eye Res 89:913–920
13. Philp NJ, Wang D, Yoon H, Hjelmeland LM (2003) Polarized expression of monocarboxy-late transporters in human retinal pigment epithelium and ARPE-19 cells. Invest Ophthalmol Vis Sci 44:1716–1721
14. Kannan R, Zhang N, Sreekumar PG, Spee CK, Rodríguez A, Barron E, Hinton DR (2006) Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. 12: 1646–1659
15. Tian, J, Ishibashi, K, Handa, JT ( 2004). The expression of native and cultured RPE grown on different matrices. Physiol Genomics. 17:170–182
16. Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88: 1343–1347
17. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P (2005) Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci. 46:349–357
18. Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20:1366–1369
19. Vincent JA, Mohr S (2007) Inhibition of cas-pase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 56:224–230